Literature DB >> 28144738

[Transorbital alternating current in optic neuropathy : December 2016. Opinion of the DOG and BVA on "Gall C et al. Alternating current stimulation for vision restoration after optic nerve damage: a randomized clinical trial. PLoS One 2016"].

.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28144738     DOI： 10.1007/s00347-016-0434-2

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN： 0941-293X            Impact factor:   1.059


× No keyword cloud information.
  4 in total

1.  Visual recovery in patients with Leber's hereditary optic neuropathy and the 11778 mutation.

Authors:  E M Stone; N J Newman; N R Miller; D R Johns; M T Lott; D C Wallace
Journal:  J Clin Neuroophthalmol       Date:  1992-03

Review 2.  How to deal with multiple endpoints in clinical trials.

Authors:  Markus Neuhäuser
Journal:  Fundam Clin Pharmacol       Date:  2006-12       Impact factor: 2.748

3.  The glaucoma research community and FDA look to the future: a report from the NEI/FDA CDER Glaucoma Clinical Trial Design and Endpoints Symposium.

Authors:  Robert N Weinreb; Paul L Kaufman
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-04       Impact factor: 4.799

4.  Alternating Current Stimulation for Vision Restoration after Optic Nerve Damage: A Randomized Clinical Trial.

Authors:  Carolin Gall; Sein Schmidt; Michael P Schittkowski; Andrea Antal; Géza Gergely Ambrus; Walter Paulus; Moritz Dannhauer; Romualda Michalik; Alf Mante; Michal Bola; Anke Lux; Siegfried Kropf; Stephan A Brandt; Bernhard A Sabel
Journal:  PLoS One       Date:  2016-06-29       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.